查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1873619

魚油EPA和DHA－全球市佔率和排名、總收入和需求預測（2025-2031年）

Fish Oil EPA and DHA - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年全球魚油 EPA 和 DHA 市場規模估計為 16.25 億美元，預計到 2031 年將成長至 20.2 億美元，在預測期（2025-2031 年）內複合年成長率為 3.4%。

本報告對近期關稅調整和國際策略反制措施對魚油EPA和DHA跨境產業佈局、資本配置模式、區域經濟相互依存關係和供應鏈重組進行了全面評估。

魚油是從富含脂肪的魚類中提取的一種脂肪。它富含二十碳五烯酸（EPA）、二十二碳六烯酸（DHA）和多種n-3多元多不飽和脂肪酸（n-3 PUFA），這些都是人體必需的營養物質。 EPA被稱為“血管清潔劑”，因為它能清除血管中的代謝廢物，保持血管彈性，並增強免疫力。 DHA被孕婦和嬰幼兒廣泛使用，它的攝取有助於促進大腦的正常生長發育，改善大腦功能，提高智力。它也被稱為“大腦黃金”。

慢性病發病率上升推動預防性營養：隨著心血管疾病、糖尿病、神經退化性疾病和全身性發炎成為全球公共衛生挑戰，人們對預防性和功能性營養的需求日益成長。 EPA 因其抗發炎和降低三酸甘油酯的作用而廣為人知，而 DHA 則有助於神經和視網膜發育。這些健康益處使得 EPA 和 DHA 成為日常營養補充劑的重要組成部分，並且擴大受到醫療專業人士的推薦。

人們對認知功能和大腦健康的日益關注正在推動對DHA的需求：隨著人口老化和兒童認知發展意識提升，DHA作為大腦和神經系統的關鍵結構成分正受到越來越多的關注。如今，DHA已被標準化添加到孕期補充劑、嬰兒奶粉和老年人認知支持產品中，使其成為Omega-3脂肪酸類別的主要推動力。

不斷壯大的中產階級和日益增強的健康意識推動了魚油補充劑的普及：在新興市場，尤其是在亞太地區，不斷壯大的中產階級和不斷提高的健康素養正推動醫療保健模式從以治療為主轉向以預防為主的自我護理。魚油補充劑正日益被視為一種經濟實惠且易於獲取的健康投資，尤其受到希望維護長期健康的家庭的青睞。

採用藥用級EPA可增強其臨床價值：處方級EPA產品，例如二十碳五烯酸乙酯，已證實其在降低心血管風險方面具有顯著的臨床療效。隨著監管機構和醫療保健系統廣泛認可這些結果，製藥業已成為一個高價值的成長平台，推動Omega-3產業進一步向醫療領域發展。

純化技術的進步提升了產品的品質和接受度：過去，人們對魚腥味、氧化和污染的擔憂阻礙了Omega-3的廣泛應用。如今，分子蒸餾、超臨界二氧化碳萃取和酯化等技術的應用，使得ω-3脂肪酸的產品更加純淨、口感更佳、生物利用度更高，顯著提高了消費者的信任度和滿意度。

本報告旨在對全球魚油 EPA/DHA 市場依地區/國家、類型和應用進行全面分析，重點關注總銷售量、收入、價格、市場佔有率和主要企業的排名。

本報告以銷售量（噸）和收入（百萬美元）為單位，對魚油EPA和DHA的市場規模、估算和預測進行了呈現，基準年為2024年，並涵蓋了2020年至2031年的歷史數據和預測數據。定量和定性分析將幫助讀者制定魚油EPA和DHA的業務和成長策略，評估市場競爭，分析自身在當前市場中的地位，並做出明智的商業決策。

市場區隔

公司

  • KD Pharma
  • Croda
  • BASF
  • Yuwang Pharma
  • GC Rieber VivoMega
  • Pelagia（EPAX）
  • Golden Omega
  • TASA
  • KinOmega Biopharm
  • Omega Protein
  • Huatai Phrama
  • AlaskOmega（Wiley Companies）
  • Jiangsu Auqi Marine Biotechnology
  • Sinomega Biotech Engineering
  • Xinzhou Marine Biological Products
  • Nu-Mega（Clover）
  • Skuny Bioscience
  • Renpu Pharmaceuticals
  • Polaris
  • Solutex

依類型分類的區隔市場

  • 魚油 EPA
  • 魚油 DHA

應用領域

  • 營養補充品
  • 強化食品和飲料
  • 嬰兒奶粉
  • 製藥
  • 寵物食品
  • 其他

依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Fish Oil EPA and DHA was estimated to be worth US$ 1625 million in 2024 and is forecast to a readjusted size of US$ 2020 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Fish Oil EPA and DHA cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Fish oil is a kind of oil extracted from fatty fish. It is rich in eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and various n-3 polyunsaturated fatty acids (n-3PUFA), which are essential unsaturated fatty acids for the human body. EPA can clean up blood vessel waste, soften blood vessels and improve immunity, and is known as the "blood vessel scavenger"; DHA is often used for pregnant women and infants. By taking DHA, it can promote the normal growth and development of the brain, thus playing a so-called brain-boosting and intelligence-enhancing effect, commonly known as "brain gold".

Rising Burden of Chronic Diseases Fuels Preventive Nutrition: As cardiovascular diseases, diabetes, neurodegenerative disorders, and systemic inflammation become global public health challenges, demand for preventive and functional nutrition is rising. EPA is well-known for its anti-inflammatory and triglyceride-lowering effects, while DHA supports neural and retinal development. These health benefits position EPA and DHA as essential components of daily supplementation, increasingly recommended by healthcare professionals.

Growing Focus on Cognitive and Brain Health Accelerates DHA Demand: With aging populations and heightened awareness of childhood cognitive development, DHA is gaining traction as a key structural component of the brain and nervous system. DHA supplementation is now routine in prenatal supplements, infant formula, and cognitive support products for aging adults, making it a central growth driver in the omega-3 category.

Expanding Middle Class and Health-Conscious Consumers Boost Uptake: In emerging markets, especially in Asia-Pacific, the expanding middle class and rising health literacy are driving the shift from curative medicine to preventive self-care. Fish oil supplements are increasingly viewed as affordable and accessible wellness investments by families looking to maintain long-term health.

Pharmaceutical-Grade EPA Adoption Reinforces Clinical Value: Prescription EPA products like icosapent ethyl have demonstrated strong clinical benefits in reducing cardiovascular risk. As more regulatory bodies and health systems embrace these results, the pharmaceutical segment is emerging as a high-value growth pillar, pushing the omega-3 industry further into the healthcare domain.

Advancements in Purification Technology Improve Quality and Appeal: Historically, concerns over fishy taste, oxidation, and contamination hindered broader omega-3 adoption. Today, molecular distillation, supercritical CO2 extraction, and re-esterification techniques have led to purer, better-tasting, and more bioavailable products, greatly enhancing consumer trust and satisfaction.

This report aims to provide a comprehensive presentation of the global market for Fish Oil EPA and DHA, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Fish Oil EPA and DHA by region & country, by Type, and by Application.

The Fish Oil EPA and DHA market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fish Oil EPA and DHA.

Market Segmentation

By Company

  • KD Pharma
  • Croda
  • BASF
  • Yuwang Pharma
  • GC Rieber VivoMega
  • Pelagia (EPAX)
  • Golden Omega
  • TASA
  • KinOmega Biopharm
  • Omega Protein
  • Huatai Phrama
  • AlaskOmega (Wiley Companies)
  • Jiangsu Auqi Marine Biotechnology
  • Sinomega Biotech Engineering
  • Xinzhou Marine Biological Products
  • Nu-Mega (Clover)
  • Skuny Bioscience
  • Renpu Pharmaceuticals
  • Polaris
  • Solutex

Segment by Type

  • Fish Oil EPA
  • Fish Oil DHA

Segment by Application

  • Dietary Supplements
  • Fortified Foods and Beverages
  • Infant Formula
  • Pharmaceuticals
  • Pet Foods
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Fish Oil EPA and DHA manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Fish Oil EPA and DHA in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Fish Oil EPA and DHA in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Fish Oil EPA and DHA Product Introduction
  • 1.2 Global Fish Oil EPA and DHA Market Size Forecast
    • 1.2.1 Global Fish Oil EPA and DHA Sales Value (2020-2031)
    • 1.2.2 Global Fish Oil EPA and DHA Sales Volume (2020-2031)
    • 1.2.3 Global Fish Oil EPA and DHA Sales Price (2020-2031)
  • 1.3 Fish Oil EPA and DHA Market Trends & Drivers
    • 1.3.1 Fish Oil EPA and DHA Industry Trends
    • 1.3.2 Fish Oil EPA and DHA Market Drivers & Opportunity
    • 1.3.3 Fish Oil EPA and DHA Market Challenges
    • 1.3.4 Fish Oil EPA and DHA Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Fish Oil EPA and DHA Players Revenue Ranking (2024)
  • 2.2 Global Fish Oil EPA and DHA Revenue by Company (2020-2025)
  • 2.3 Global Fish Oil EPA and DHA Players Sales Volume Ranking (2024)
  • 2.4 Global Fish Oil EPA and DHA Sales Volume by Company Players (2020-2025)
  • 2.5 Global Fish Oil EPA and DHA Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Fish Oil EPA and DHA Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Fish Oil EPA and DHA Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Fish Oil EPA and DHA
  • 2.9 Fish Oil EPA and DHA Market Competitive Analysis
    • 2.9.1 Fish Oil EPA and DHA Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Fish Oil EPA and DHA Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fish Oil EPA and DHA as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Fish Oil EPA
    • 3.1.2 Fish Oil DHA
  • 3.2 Global Fish Oil EPA and DHA Sales Value by Type
    • 3.2.1 Global Fish Oil EPA and DHA Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Fish Oil EPA and DHA Sales Value, by Type (2020-2031)
    • 3.2.3 Global Fish Oil EPA and DHA Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Fish Oil EPA and DHA Sales Volume by Type
    • 3.3.1 Global Fish Oil EPA and DHA Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Fish Oil EPA and DHA Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Fish Oil EPA and DHA Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Fish Oil EPA and DHA Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Dietary Supplements
    • 4.1.2 Fortified Foods and Beverages
    • 4.1.3 Infant Formula
    • 4.1.4 Pharmaceuticals
    • 4.1.5 Pet Foods
    • 4.1.6 Others
  • 4.2 Global Fish Oil EPA and DHA Sales Value by Application
    • 4.2.1 Global Fish Oil EPA and DHA Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Fish Oil EPA and DHA Sales Value, by Application (2020-2031)
    • 4.2.3 Global Fish Oil EPA and DHA Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Fish Oil EPA and DHA Sales Volume by Application
    • 4.3.1 Global Fish Oil EPA and DHA Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Fish Oil EPA and DHA Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Fish Oil EPA and DHA Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Fish Oil EPA and DHA Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Fish Oil EPA and DHA Sales Value by Region
    • 5.1.1 Global Fish Oil EPA and DHA Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Fish Oil EPA and DHA Sales Value by Region (2020-2025)
    • 5.1.3 Global Fish Oil EPA and DHA Sales Value by Region (2026-2031)
    • 5.1.4 Global Fish Oil EPA and DHA Sales Value by Region (%), (2020-2031)
  • 5.2 Global Fish Oil EPA and DHA Sales Volume by Region
    • 5.2.1 Global Fish Oil EPA and DHA Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Fish Oil EPA and DHA Sales Volume by Region (2020-2025)
    • 5.2.3 Global Fish Oil EPA and DHA Sales Volume by Region (2026-2031)
    • 5.2.4 Global Fish Oil EPA and DHA Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Fish Oil EPA and DHA Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Fish Oil EPA and DHA Sales Value, 2020-2031
    • 5.4.2 North America Fish Oil EPA and DHA Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Fish Oil EPA and DHA Sales Value, 2020-2031
    • 5.5.2 Europe Fish Oil EPA and DHA Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Fish Oil EPA and DHA Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Fish Oil EPA and DHA Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Fish Oil EPA and DHA Sales Value, 2020-2031
    • 5.7.2 South America Fish Oil EPA and DHA Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Fish Oil EPA and DHA Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Fish Oil EPA and DHA Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Fish Oil EPA and DHA Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Fish Oil EPA and DHA Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Fish Oil EPA and DHA Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Fish Oil EPA and DHA Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Fish Oil EPA and DHA Sales Value, 2020-2031
    • 6.3.2 United States Fish Oil EPA and DHA Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Fish Oil EPA and DHA Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Fish Oil EPA and DHA Sales Value, 2020-2031
    • 6.4.2 Europe Fish Oil EPA and DHA Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Fish Oil EPA and DHA Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Fish Oil EPA and DHA Sales Value, 2020-2031
    • 6.5.2 China Fish Oil EPA and DHA Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Fish Oil EPA and DHA Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Fish Oil EPA and DHA Sales Value, 2020-2031
    • 6.6.2 Japan Fish Oil EPA and DHA Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Fish Oil EPA and DHA Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Fish Oil EPA and DHA Sales Value, 2020-2031
    • 6.7.2 South Korea Fish Oil EPA and DHA Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Fish Oil EPA and DHA Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Fish Oil EPA and DHA Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Fish Oil EPA and DHA Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Fish Oil EPA and DHA Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Fish Oil EPA and DHA Sales Value, 2020-2031
    • 6.9.2 India Fish Oil EPA and DHA Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Fish Oil EPA and DHA Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 KD Pharma
    • 7.1.1 KD Pharma Company Information
    • 7.1.2 KD Pharma Introduction and Business Overview
    • 7.1.3 KD Pharma Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 KD Pharma Fish Oil EPA and DHA Product Offerings
    • 7.1.5 KD Pharma Recent Development
  • 7.2 Croda
    • 7.2.1 Croda Company Information
    • 7.2.2 Croda Introduction and Business Overview
    • 7.2.3 Croda Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Croda Fish Oil EPA and DHA Product Offerings
    • 7.2.5 Croda Recent Development
  • 7.3 BASF
    • 7.3.1 BASF Company Information
    • 7.3.2 BASF Introduction and Business Overview
    • 7.3.3 BASF Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 BASF Fish Oil EPA and DHA Product Offerings
    • 7.3.5 BASF Recent Development
  • 7.4 Yuwang Pharma
    • 7.4.1 Yuwang Pharma Company Information
    • 7.4.2 Yuwang Pharma Introduction and Business Overview
    • 7.4.3 Yuwang Pharma Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Yuwang Pharma Fish Oil EPA and DHA Product Offerings
    • 7.4.5 Yuwang Pharma Recent Development
  • 7.5 GC Rieber VivoMega
    • 7.5.1 GC Rieber VivoMega Company Information
    • 7.5.2 GC Rieber VivoMega Introduction and Business Overview
    • 7.5.3 GC Rieber VivoMega Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 GC Rieber VivoMega Fish Oil EPA and DHA Product Offerings
    • 7.5.5 GC Rieber VivoMega Recent Development
  • 7.6 Pelagia (EPAX)
    • 7.6.1 Pelagia (EPAX) Company Information
    • 7.6.2 Pelagia (EPAX) Introduction and Business Overview
    • 7.6.3 Pelagia (EPAX) Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Pelagia (EPAX) Fish Oil EPA and DHA Product Offerings
    • 7.6.5 Pelagia (EPAX) Recent Development
  • 7.7 Golden Omega
    • 7.7.1 Golden Omega Company Information
    • 7.7.2 Golden Omega Introduction and Business Overview
    • 7.7.3 Golden Omega Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Golden Omega Fish Oil EPA and DHA Product Offerings
    • 7.7.5 Golden Omega Recent Development
  • 7.8 TASA
    • 7.8.1 TASA Company Information
    • 7.8.2 TASA Introduction and Business Overview
    • 7.8.3 TASA Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 TASA Fish Oil EPA and DHA Product Offerings
    • 7.8.5 TASA Recent Development
  • 7.9 KinOmega Biopharm
    • 7.9.1 KinOmega Biopharm Company Information
    • 7.9.2 KinOmega Biopharm Introduction and Business Overview
    • 7.9.3 KinOmega Biopharm Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 KinOmega Biopharm Fish Oil EPA and DHA Product Offerings
    • 7.9.5 KinOmega Biopharm Recent Development
  • 7.10 Omega Protein
    • 7.10.1 Omega Protein Company Information
    • 7.10.2 Omega Protein Introduction and Business Overview
    • 7.10.3 Omega Protein Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 Omega Protein Fish Oil EPA and DHA Product Offerings
    • 7.10.5 Omega Protein Recent Development
  • 7.11 Huatai Phrama
    • 7.11.1 Huatai Phrama Company Information
    • 7.11.2 Huatai Phrama Introduction and Business Overview
    • 7.11.3 Huatai Phrama Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.11.4 Huatai Phrama Fish Oil EPA and DHA Product Offerings
    • 7.11.5 Huatai Phrama Recent Development
  • 7.12 AlaskOmega (Wiley Companies)
    • 7.12.1 AlaskOmega (Wiley Companies) Company Information
    • 7.12.2 AlaskOmega (Wiley Companies) Introduction and Business Overview
    • 7.12.3 AlaskOmega (Wiley Companies) Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.12.4 AlaskOmega (Wiley Companies) Fish Oil EPA and DHA Product Offerings
    • 7.12.5 AlaskOmega (Wiley Companies) Recent Development
  • 7.13 Jiangsu Auqi Marine Biotechnology
    • 7.13.1 Jiangsu Auqi Marine Biotechnology Company Information
    • 7.13.2 Jiangsu Auqi Marine Biotechnology Introduction and Business Overview
    • 7.13.3 Jiangsu Auqi Marine Biotechnology Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.13.4 Jiangsu Auqi Marine Biotechnology Fish Oil EPA and DHA Product Offerings
    • 7.13.5 Jiangsu Auqi Marine Biotechnology Recent Development
  • 7.14 Sinomega Biotech Engineering
    • 7.14.1 Sinomega Biotech Engineering Company Information
    • 7.14.2 Sinomega Biotech Engineering Introduction and Business Overview
    • 7.14.3 Sinomega Biotech Engineering Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.14.4 Sinomega Biotech Engineering Fish Oil EPA and DHA Product Offerings
    • 7.14.5 Sinomega Biotech Engineering Recent Development
  • 7.15 Xinzhou Marine Biological Products
    • 7.15.1 Xinzhou Marine Biological Products Company Information
    • 7.15.2 Xinzhou Marine Biological Products Introduction and Business Overview
    • 7.15.3 Xinzhou Marine Biological Products Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.15.4 Xinzhou Marine Biological Products Fish Oil EPA and DHA Product Offerings
    • 7.15.5 Xinzhou Marine Biological Products Recent Development
  • 7.16 Nu-Mega (Clover)
    • 7.16.1 Nu-Mega (Clover) Company Information
    • 7.16.2 Nu-Mega (Clover) Introduction and Business Overview
    • 7.16.3 Nu-Mega (Clover) Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.16.4 Nu-Mega (Clover) Fish Oil EPA and DHA Product Offerings
    • 7.16.5 Nu-Mega (Clover) Recent Development
  • 7.17 Skuny Bioscience
    • 7.17.1 Skuny Bioscience Company Information
    • 7.17.2 Skuny Bioscience Introduction and Business Overview
    • 7.17.3 Skuny Bioscience Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.17.4 Skuny Bioscience Fish Oil EPA and DHA Product Offerings
    • 7.17.5 Skuny Bioscience Recent Development
  • 7.18 Renpu Pharmaceuticals
    • 7.18.1 Renpu Pharmaceuticals Company Information
    • 7.18.2 Renpu Pharmaceuticals Introduction and Business Overview
    • 7.18.3 Renpu Pharmaceuticals Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.18.4 Renpu Pharmaceuticals Fish Oil EPA and DHA Product Offerings
    • 7.18.5 Renpu Pharmaceuticals Recent Development
  • 7.19 Polaris
    • 7.19.1 Polaris Company Information
    • 7.19.2 Polaris Introduction and Business Overview
    • 7.19.3 Polaris Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.19.4 Polaris Fish Oil EPA and DHA Product Offerings
    • 7.19.5 Polaris Recent Development
  • 7.20 Solutex
    • 7.20.1 Solutex Company Information
    • 7.20.2 Solutex Introduction and Business Overview
    • 7.20.3 Solutex Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.20.4 Solutex Fish Oil EPA and DHA Product Offerings
    • 7.20.5 Solutex Recent Development

8 Industry Chain Analysis

  • 8.1 Fish Oil EPA and DHA Industrial Chain
  • 8.2 Fish Oil EPA and DHA Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Fish Oil EPA and DHA Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Fish Oil EPA and DHA Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Fish Oil EPA and DHA Market Trends
  • Table 2. Fish Oil EPA and DHA Market Drivers & Opportunity
  • Table 3. Fish Oil EPA and DHA Market Challenges
  • Table 4. Fish Oil EPA and DHA Market Restraints
  • Table 5. Global Fish Oil EPA and DHA Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Fish Oil EPA and DHA Revenue Market Share by Company (2020-2025)
  • Table 7. Global Fish Oil EPA and DHA Sales Volume by Company (2020-2025) & (Tons)
  • Table 8. Global Fish Oil EPA and DHA Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Fish Oil EPA and DHA Price by Company (2020-2025) & (US$/Ton)
  • Table 10. Key Manufacturers Fish Oil EPA and DHA Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Fish Oil EPA and DHA Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Fish Oil EPA and DHA
  • Table 13. Global Fish Oil EPA and DHA Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fish Oil EPA and DHA as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Fish Oil EPA and DHA Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Fish Oil EPA and DHA Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Fish Oil EPA and DHA Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Fish Oil EPA and DHA Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Fish Oil EPA and DHA Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Fish Oil EPA and DHA Sales Volume by Type: 2020 VS 2024 VS 2031 (Tons)
  • Table 22. Global Fish Oil EPA and DHA Sales Volume by Type (2020-2025) & (Tons)
  • Table 23. Global Fish Oil EPA and DHA Sales Volume by Type (2026-2031) & (Tons)
  • Table 24. Global Fish Oil EPA and DHA Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Fish Oil EPA and DHA Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Fish Oil EPA and DHA Price by Type (2020-2025) & (US$/Ton)
  • Table 27. Global Fish Oil EPA and DHA Price by Type (2026-2031) & (US$/Ton)
  • Table 28. Global Fish Oil EPA and DHA Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Fish Oil EPA and DHA Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Fish Oil EPA and DHA Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Fish Oil EPA and DHA Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Fish Oil EPA and DHA Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Fish Oil EPA and DHA Sales Volume by Application: 2020 VS 2024 VS 2031 (Tons)
  • Table 34. Global Fish Oil EPA and DHA Sales Volume by Application (2020-2025) & (Tons)
  • Table 35. Global Fish Oil EPA and DHA Sales Volume by Application (2026-2031) & (Tons)
  • Table 36. Global Fish Oil EPA and DHA Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Fish Oil EPA and DHA Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Fish Oil EPA and DHA Price by Application (2020-2025) & (US$/Ton)
  • Table 39. Global Fish Oil EPA and DHA Price by Application (2026-2031) & (US$/Ton)
  • Table 40. Global Fish Oil EPA and DHA Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Fish Oil EPA and DHA Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Fish Oil EPA and DHA Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Fish Oil EPA and DHA Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Fish Oil EPA and DHA Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Fish Oil EPA and DHA Sales Volume by Region (Tons): 2020 VS 2024 VS 2031
  • Table 46. Global Fish Oil EPA and DHA Sales Volume by Region (2020-2025) & (Tons)
  • Table 47. Global Fish Oil EPA and DHA Sales Volume by Region (2026-2031) & (Tons)
  • Table 48. Global Fish Oil EPA and DHA Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Fish Oil EPA and DHA Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Fish Oil EPA and DHA Average Price by Region (2020-2025) & (US$/Ton)
  • Table 51. Global Fish Oil EPA and DHA Average Price by Region (2026-2031) & (US$/Ton)
  • Table 52. Key Countries/Regions Fish Oil EPA and DHA Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Fish Oil EPA and DHA Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Fish Oil EPA and DHA Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Fish Oil EPA and DHA Sales Volume, (2020-2025) & (Tons)
  • Table 56. Key Countries/Regions Fish Oil EPA and DHA Sales Volume, (2026-2031) & (Tons)
  • Table 57. KD Pharma Company Information
  • Table 58. KD Pharma Introduction and Business Overview
  • Table 59. KD Pharma Fish Oil EPA and DHA Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 60. KD Pharma Fish Oil EPA and DHA Product Offerings
  • Table 61. KD Pharma Recent Development
  • Table 62. Croda Company Information
  • Table 63. Croda Introduction and Business Overview
  • Table 64. Croda Fish Oil EPA and DHA Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 65. Croda Fish Oil EPA and DHA Product Offerings
  • Table 66. Croda Recent Development
  • Table 67. BASF Company Information
  • Table 68. BASF Introduction and Business Overview
  • Table 69. BASF Fish Oil EPA and DHA Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 70. BASF Fish Oil EPA and DHA Product Offerings
  • Table 71. BASF Recent Development
  • Table 72. Yuwang Pharma Company Information
  • Table 73. Yuwang Pharma Introduction and Business Overview
  • Table 74. Yuwang Pharma Fish Oil EPA and DHA Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 75. Yuwang Pharma Fish Oil EPA and DHA Product Offerings
  • Table 76. Yuwang Pharma Recent Development
  • Table 77. GC Rieber VivoMega Company Information
  • Table 78. GC Rieber VivoMega Introduction and Business Overview
  • Table 79. GC Rieber VivoMega Fish Oil EPA and DHA Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 80. GC Rieber VivoMega Fish Oil EPA and DHA Product Offerings
  • Table 81. GC Rieber VivoMega Recent Development
  • Table 82. Pelagia (EPAX) Company Information
  • Table 83. Pelagia (EPAX) Introduction and Business Overview
  • Table 84. Pelagia (EPAX) Fish Oil EPA and DHA Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 85. Pelagia (EPAX) Fish Oil EPA and DHA Product Offerings
  • Table 86. Pelagia (EPAX) Recent Development
  • Table 87. Golden Omega Company Information
  • Table 88. Golden Omega Introduction and Business Overview
  • Table 89. Golden Omega Fish Oil EPA and DHA Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 90. Golden Omega Fish Oil EPA and DHA Product Offerings
  • Table 91. Golden Omega Recent Development
  • Table 92. TASA Company Information
  • Table 93. TASA Introduction and Business Overview
  • Table 94. TASA Fish Oil EPA and DHA Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 95. TASA Fish Oil EPA and DHA Product Offerings
  • Table 96. TASA Recent Development
  • Table 97. KinOmega Biopharm Company Information
  • Table 98. KinOmega Biopharm Introduction and Business Overview
  • Table 99. KinOmega Biopharm Fish Oil EPA and DHA Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 100. KinOmega Biopharm Fish Oil EPA and DHA Product Offerings
  • Table 101. KinOmega Biopharm Recent Development
  • Table 102. Omega Protein Company Information
  • Table 103. Omega Protein Introduction and Business Overview
  • Table 104. Omega Protein Fish Oil EPA and DHA Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 105. Omega Protein Fish Oil EPA and DHA Product Offerings
  • Table 106. Omega Protein Recent Development
  • Table 107. Huatai Phrama Company Information
  • Table 108. Huatai Phrama Introduction and Business Overview
  • Table 109. Huatai Phrama Fish Oil EPA and DHA Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 110. Huatai Phrama Fish Oil EPA and DHA Product Offerings
  • Table 111. Huatai Phrama Recent Development
  • Table 112. AlaskOmega (Wiley Companies) Company Information
  • Table 113. AlaskOmega (Wiley Companies) Introduction and Business Overview
  • Table 114. AlaskOmega (Wiley Companies) Fish Oil EPA and DHA Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 115. AlaskOmega (Wiley Companies) Fish Oil EPA and DHA Product Offerings
  • Table 116. AlaskOmega (Wiley Companies) Recent Development
  • Table 117. Jiangsu Auqi Marine Biotechnology Company Information
  • Table 118. Jiangsu Auqi Marine Biotechnology Introduction and Business Overview
  • Table 119. Jiangsu Auqi Marine Biotechnology Fish Oil EPA and DHA Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 120. Jiangsu Auqi Marine Biotechnology Fish Oil EPA and DHA Product Offerings
  • Table 121. Jiangsu Auqi Marine Biotechnology Recent Development
  • Table 122. Sinomega Biotech Engineering Company Information
  • Table 123. Sinomega Biotech Engineering Introduction and Business Overview
  • Table 124. Sinomega Biotech Engineering Fish Oil EPA and DHA Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 125. Sinomega Biotech Engineering Fish Oil EPA and DHA Product Offerings
  • Table 126. Sinomega Biotech Engineering Recent Development
  • Table 127. Xinzhou Marine Biological Products Company Information
  • Table 128. Xinzhou Marine Biological Products Introduction and Business Overview
  • Table 129. Xinzhou Marine Biological Products Fish Oil EPA and DHA Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 130. Xinzhou Marine Biological Products Fish Oil EPA and DHA Product Offerings
  • Table 131. Xinzhou Marine Biological Products Recent Development
  • Table 132. Nu-Mega (Clover) Company Information
  • Table 133. Nu-Mega (Clover) Introduction and Business Overview
  • Table 134. Nu-Mega (Clover) Fish Oil EPA and DHA Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 135. Nu-Mega (Clover) Fish Oil EPA and DHA Product Offerings
  • Table 136. Nu-Mega (Clover) Recent Development
  • Table 137. Skuny Bioscience Company Information
  • Table 138. Skuny Bioscience Introduction and Business Overview
  • Table 139. Skuny Bioscience Fish Oil EPA and DHA Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 140. Skuny Bioscience Fish Oil EPA and DHA Product Offerings
  • Table 141. Skuny Bioscience Recent Development
  • Table 142. Renpu Pharmaceuticals Company Information
  • Table 143. Renpu Pharmaceuticals Introduction and Business Overview
  • Table 144. Renpu Pharmaceuticals Fish Oil EPA and DHA Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 145. Renpu Pharmaceuticals Fish Oil EPA and DHA Product Offerings
  • Table 146. Renpu Pharmaceuticals Recent Development
  • Table 147. Polaris Company Information
  • Table 148. Polaris Introduction and Business Overview
  • Table 149. Polaris Fish Oil EPA and DHA Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 150. Polaris Fish Oil EPA and DHA Product Offerings
  • Table 151. Polaris Recent Development
  • Table 152. Solutex Company Information
  • Table 153. Solutex Introduction and Business Overview
  • Table 154. Solutex Fish Oil EPA and DHA Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 155. Solutex Fish Oil EPA and DHA Product Offerings
  • Table 156. Solutex Recent Development
  • Table 157. Key Raw Materials Lists
  • Table 158. Raw Materials Key Suppliers Lists
  • Table 159. Fish Oil EPA and DHA Downstream Customers
  • Table 160. Fish Oil EPA and DHA Distributors List
  • Table 161. Research Programs/Design for This Report
  • Table 162. Key Data Information from Secondary Sources
  • Table 163. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Fish Oil EPA and DHA Product Picture
  • Figure 2. Global Fish Oil EPA and DHA Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Fish Oil EPA and DHA Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Fish Oil EPA and DHA Sales Volume (2020-2031) & (Tons)
  • Figure 5. Global Fish Oil EPA and DHA Sales Price (2020-2031) & (US$/Ton)
  • Figure 6. Fish Oil EPA and DHA Report Years Considered
  • Figure 7. Global Fish Oil EPA and DHA Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Fish Oil EPA and DHA Players Sales Volume Ranking (2024) & (Tons)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Fish Oil EPA and DHA Revenue in 2024
  • Figure 10. Fish Oil EPA and DHA Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Fish Oil EPA Picture
  • Figure 12. Fish Oil DHA Picture
  • Figure 13. Global Fish Oil EPA and DHA Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 14. Global Fish Oil EPA and DHA Sales Value Market Share by Type, 2024 & 2031
  • Figure 15. Global Fish Oil EPA and DHA Sales Volume by Type (2020 VS 2024 VS 2031) & (Tons)
  • Figure 16. Global Fish Oil EPA and DHA Sales Volume Market Share by Type, 2024 & 2031
  • Figure 17. Global Fish Oil EPA and DHA Price by Type (2020-2031) & (US$/Ton)
  • Figure 18. Product Picture of Dietary Supplements
  • Figure 19. Product Picture of Fortified Foods and Beverages
  • Figure 20. Product Picture of Infant Formula
  • Figure 21. Product Picture of Pharmaceuticals
  • Figure 22. Product Picture of Pet Foods
  • Figure 23. Product Picture of Others
  • Figure 24. Global Fish Oil EPA and DHA Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 25. Global Fish Oil EPA and DHA Sales Value Market Share by Application, 2024 & 2031
  • Figure 26. Global Fish Oil EPA and DHA Sales Volume by Application (2020 VS 2024 VS 2031) & (Tons)
  • Figure 27. Global Fish Oil EPA and DHA Sales Volume Market Share by Application, 2024 & 2031
  • Figure 28. Global Fish Oil EPA and DHA Price by Application (2020-2031) & (US$/Ton)
  • Figure 29. North America Fish Oil EPA and DHA Sales Value (2020-2031) & (US$ Million)
  • Figure 30. North America Fish Oil EPA and DHA Sales Value by Country (%), 2024 VS 2031
  • Figure 31. Europe Fish Oil EPA and DHA Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. Europe Fish Oil EPA and DHA Sales Value by Country (%), 2024 VS 2031
  • Figure 33. Asia Pacific Fish Oil EPA and DHA Sales Value, (2020-2031) & (US$ Million)
  • Figure 34. Asia Pacific Fish Oil EPA and DHA Sales Value by Region (%), 2024 VS 2031
  • Figure 35. South America Fish Oil EPA and DHA Sales Value, (2020-2031) & (US$ Million)
  • Figure 36. South America Fish Oil EPA and DHA Sales Value by Country (%), 2024 VS 2031
  • Figure 37. Middle East & Africa Fish Oil EPA and DHA Sales Value, (2020-2031) & (US$ Million)
  • Figure 38. Middle East & Africa Fish Oil EPA and DHA Sales Value by Country (%), 2024 VS 2031
  • Figure 39. Key Countries/Regions Fish Oil EPA and DHA Sales Value (%), (2020-2031)
  • Figure 40. Key Countries/Regions Fish Oil EPA and DHA Sales Volume (%), (2020-2031)
  • Figure 41. United States Fish Oil EPA and DHA Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. United States Fish Oil EPA and DHA Sales Value by Type (%), 2024 VS 2031
  • Figure 43. United States Fish Oil EPA and DHA Sales Value by Application (%), 2024 VS 2031
  • Figure 44. Europe Fish Oil EPA and DHA Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. Europe Fish Oil EPA and DHA Sales Value by Type (%), 2024 VS 2031
  • Figure 46. Europe Fish Oil EPA and DHA Sales Value by Application (%), 2024 VS 2031
  • Figure 47. China Fish Oil EPA and DHA Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. China Fish Oil EPA and DHA Sales Value by Type (%), 2024 VS 2031
  • Figure 49. China Fish Oil EPA and DHA Sales Value by Application (%), 2024 VS 2031
  • Figure 50. Japan Fish Oil EPA and DHA Sales Value, (2020-2031) & (US$ Million)
  • Figure 51. Japan Fish Oil EPA and DHA Sales Value by Type (%), 2024 VS 2031
  • Figure 52. Japan Fish Oil EPA and DHA Sales Value by Application (%), 2024 VS 2031
  • Figure 53. South Korea Fish Oil EPA and DHA Sales Value, (2020-2031) & (US$ Million)
  • Figure 54. South Korea Fish Oil EPA and DHA Sales Value by Type (%), 2024 VS 2031
  • Figure 55. South Korea Fish Oil EPA and DHA Sales Value by Application (%), 2024 VS 2031
  • Figure 56. Southeast Asia Fish Oil EPA and DHA Sales Value, (2020-2031) & (US$ Million)
  • Figure 57. Southeast Asia Fish Oil EPA and DHA Sales Value by Type (%), 2024 VS 2031
  • Figure 58. Southeast Asia Fish Oil EPA and DHA Sales Value by Application (%), 2024 VS 2031
  • Figure 59. India Fish Oil EPA and DHA Sales Value, (2020-2031) & (US$ Million)
  • Figure 60. India Fish Oil EPA and DHA Sales Value by Type (%), 2024 VS 2031
  • Figure 61. India Fish Oil EPA and DHA Sales Value by Application (%), 2024 VS 2031
  • Figure 62. Fish Oil EPA and DHA Industrial Chain
  • Figure 63. Fish Oil EPA and DHA Manufacturing Cost Structure
  • Figure 64. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 65. Bottom-up and Top-down Approaches for This Report
  • Figure 66. Data Triangulation
  • Figure 67. Key Executives Interviewed